Science
Mechanism of Action
Functions as a dual-pathway active: inhibits tyrosinase enzyme through bioactive compounds Kazinol C and Kazinol F to reduce melanin production, while simultaneously suppressing inflammatory markers (IgE, IL-4, hTARC) via NF-kB and p38 MAPK pathway modulation. Additionally provides collagenase inhibition for anti-aging benefits.
Research
Clinical Evidence
High confidence0.05%
Key findings
- 01 87% inhibition of hTARC secretion at 0.05% concentration in keratinocyte cells
- 02 Superior atopic dermatitis lesion suppression vs 0.1% tacrolimus at 0.1% concentration
- 03 Dose-dependent tyrosinase inhibition with greater efficacy than kojic acid at 0.02-0.1%
Transparency
Dusting Analysis
Effective concentrations start at 0.02%, making sub-0.01% levels inadequate for therapeutic benefits. The significant difference between effective doses and trace amounts makes dusting detection straightforward.
The Formula
Formulation
Stability
Exhibits high sensitivity to thermal and photodegradation; active kazinol compounds require protection from temperatures exceeding 45°C and UV exposure. Microencapsulation recommended for enhanced stability.
Synergies
- niacinamide
- vitamin C
- hyaluronic acid
Conflicts
- high temperature processing
- strong oxidizing agents
- prolonged UV exposure
Safety
Safety Profile
Generally recognized as safe in cosmetic applications with typical usage below 1% concentration. Safety profile supported by related botanical bark extract assessments.
Your Skin
Skin Compatibility
Our Assessment
Verdict
A scientifically-backed botanical brightening agent that offers superior efficacy compared to traditional alternatives like kojic acid, with excellent tolerability across all skin types.
Related
Similar Ingredients
Finding similar ingredients…